European Conference on Interventional Oncology
ECIO countries

April 26 - 30 | Basel, CH

April 26-30 | Basel, CH

April 26-30 | Basel, CH

April 26-30 | Basel, CH

April 26-30 | Basel, CH

Slider
ProgrammeHonorary Lecture

Honorary Lecture

Interventional oncology 2030: challenges and opportunities for the next generation

Tuesday, April 28, 10:30-11:45

Afshin Gangi
Afshin Gangi
ECIO 2026 Honorary Lecturer
(Strasbourg/FR)

About Prof. Gangi

Prof. Afshin Gangi received his education at the International French School of Tehran, graduating in 1980. During the summer of that year, he began medical school at the University of Reims in France, earning his degree in 1987. He began his residency in Strasbourg in 1987, first in the intensive care unit and the pneumology department, where he became excited about imaging and moved to the imaging department. After his residency in general radiology and neuroradiology, he worked for one year in interventional radiology with Professor R.F. Dondelinger in Luxembourg.

Prof. Gangi began his fellowship in Strasbourg in November 1991 in the department of neuroradiology and MSK with a special interest in percutaneous procedures. He performed his first vertebroplasty in 1989 during his residency and continued to develop image-guided procedures in interventional oncology, especially under CT-C arm fluoroscopy and MR guidance.  In 1995, Prof. Gangi obtained his Ph.D. in laser physics in Strasbourg. During the same year, he was appointed assistant professor at the University Hospital of Strasbourg’s Institute of Image-Guided Surgery (IHU), and he became a full professor of Radiology in 2000. Since 2014, he has worked with Prof. Andy Adam at King’s College London as an invited professor for research in interventional oncology and HIFU.

Throughout his career, one of Prof. Gangi’s main interests has been cancer treatment. It was his team that first performed bone metastasis treatment for pain management with ethanol in 1992, the first laser ablation of a bone tumour, the first cryoablation of a MSK tumour, then a kidney in Europe. Prof. Gangi has also been extremely active in cancer research, with multiple multicentre tumour ablation studies on kidney tumours and MSK tumours. Recently with ICUB labs, a second interventional MR with 0.5 Tesla has been installed in IHU.

Always ready to share his knowledge, Prof. Gangi has organized numerous courses at the IHU in cooperation with CIRSE’s European School of Interventional Radiology (ESIR).

Prof. Gangi holds numerous patents and is an author of more than 300 peer-reviewed articles. He has more than 40 book chapters to his credit, along with over 500 abstracts at numerous national and international conferences.

Following his decades-long dedication to CIRSE and his tenure as the society’s president, Prof. Gangi was awarded the CIRSE Gold Medal in 2025.